Our results showed that SFN inhibited Ang II‐induced cardiac hypertrophy (Figure 1), inflammatory factor expression (Figure 2A), oxidative stress (Figure 2B) and fibrosis (Figure 2C‐D), and significantly improved cardiac dysfunction (Figure 1A). This evidence concerns the gene AGT and cardiac hypertrophy.